Effectiveness of behavioural graded activity compared with physiotherapy treatment in chronic neck pain: a randomised clinical trial

ISRCTN ISRCTN88733332
DOI https://doi.org/10.1186/ISRCTN88733332
Secondary identifying numbers N/A
Submission date
14/09/2004
Registration date
15/09/2004
Last edited
15/04/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Bart Koes
Scientific

PO Box 1738
Rotterdam
3000 DR
Netherlands

Phone +31 (0)10 4087620
Email b.koes@erasmusmc.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study acronymEphysion (Effectiveness Physiotherapy in Neck pain)
Study objectivesA randomised clinical trial (RCT) has been designed to assess the effectiveness of behavioural graded activity compared with physiotherapy treatment in patients with chronic non-specific neck pain.
Ethics approval(s)The study design has been approved by the Medical Ethics Technical Commission of the Erasmus MC, University Medical Centre in Rotterdam and is in compliance with the Helsinki Declaration.
Health condition(s) or problem(s) studiedChronic non-specific neck pain
InterventionThe behavioural graded activity program is based on an operant approach, which uses a time-contingent method to increase the patient's activity level. This program is compared with a physiotherapy treatment using a pain-contingent method.
Intervention typeOther
Primary outcome measure'Global perceived effect' (neck complaint and functioning in daily activities) (1 - 7 on the Likert scale), measured at 4, 9, 26 and 52 weeks.
Secondary outcome measures1. Main complaint (0 – 10 on the Likert scale), measured at baseline, 4, 9, 26 and 52 weeks
2. Pain (Visual Analogue Scale [VAS]), measured at baseline, 4, 9, 26 and 52 weeks
3. Medical consumption (dose per day), measured at baseline, 4, 9, 26 and 52 weeks
4. Coping with Multi-dimensional pain (Multidimensional Pain inventory [MPI] Part I-II and 0 – 6 on the Likert scale), measured at baseline, 9, 26 and 52 weeks
5. Activity (MPI, part III) (0 – 6 on the Likert scale), measured at baseline, 4, 9, 26 and 52 weeks
6. Specific functional status (Neck Disability Index [NDI]), measured at baseline, 4, 9, 26 and 52 weeks
7. Quality of life, measured using the 36-item Short Form (SF-36) at baseline, 9, 26 and 52 weeks, and the Euroquol 5-Dutch language version (EQ-5d) at baseline, 4, 9, 26 and 52 weeks
8. Work activities Hours/week, measured at baseline, 9, 26 and 52 weeks
9. Satisfaction about treatment (1 – 5 on the Likert scale), measured at 4, 9 and 26 weeks
10. Compliance with treatment exercise (number and time per week), measured at 4, 9, 26 and 52 weeks
11. Additional treatments Discipline and number of treatments, measured at 4, 9, 26 and 52 weeks
12. Side-effects (yes – no and any additional elucidation), measured at 4, 9, 26 and 52 weeks
Overall study start date01/01/2004
Completion date31/12/2005

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants80 per treatment group (160 total)
Key inclusion criteria1. Aged between 18 and 70 years old
2. Have suffered from neck pain for over three months
3. Have an adequate knowledge of the Dutch language

Excluded are patients diagnosed with a specific disorder (e.g. a slipped disc, a tumour or a lesion in the cervical spine), those who have had physical/manual therapy during the previous six months, those with a chronic disease (e.g. rheumatoid arthritis or coronary artery disease), or those who have to undergo surgery in the near future.
Key exclusion criteria1. Diagnosed with a specific disorder (e.g. a slipped disc, a tumour or a lesion in the cervical spine)
2. Have had physical/manual therapy during the previous six months
3. With a chronic disease (e.g. rheumatoid arthritis or coronary artery disease)
4. Who have to undergo surgery in the near future
Date of first enrolment01/01/2004
Date of final enrolment31/12/2005

Locations

Countries of recruitment

  • Netherlands

Study participating centre

PO Box 1738
Rotterdam
3000 DR
Netherlands

Sponsor information

Erasmus Medical Centre (Netherlands)
Hospital/treatment centre

Dept. of General Practice
PO Box 1738
Rotterdam
3000 DR
Netherlands

Phone +31 (0)10 4087613
Email b.koes@erasmusmc.nl
Website http://www.erasmusmc.nl/
ROR logo "ROR" https://ror.org/018906e22

Funders

Funder type

Government

The Dutch Health Care Insurance Board (College voor zorgverzekeringen [CVZ]) (Netherlands) (ref: DPZ 01-01)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article Protocol 06/10/2004 Yes No
Results article results 01/05/2009 Yes No